Literature DB >> 7861485

Carcinoma in situ of the bladder.

M A Hudson1, H W Herr.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7861485     DOI: 10.1097/00005392-199503000-00002

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  18 in total

Review 1.  Valrubicin.

Authors:  S V Onrust; H M Lamb
Journal:  Drugs Aging       Date:  1999-07       Impact factor: 3.923

2.  Clinical outcome of primary versus secondary bladder carcinoma in situ.

Authors:  Daher C Chade; Shahrokh F Shariat; Ari Adamy; Bernard H Bochner; S Machele Donat; Harry W Herr; Guido Dalbagni
Journal:  J Urol       Date:  2010-06-17       Impact factor: 7.450

3.  Evaluation of urovysion and cytology for bladder cancer detection: a study of 1835 paired urine samples with clinical and histologic correlation.

Authors:  Haythem Dimashkieh; Daynna J Wolff; T Michael Smith; Patricia M Houser; Paul J Nietert; Jack Yang
Journal:  Cancer Cytopathol       Date:  2013-06-25       Impact factor: 5.284

4.  Phosphodiesterase 5 inhibitors enhance chemotherapy killing in gastrointestinal/genitourinary cancer cells.

Authors:  Laurence Booth; Jane L Roberts; Nichola Cruickshanks; Adam Conley; David E Durrant; Anindita Das; Paul B Fisher; Rakesh C Kukreja; Steven Grant; Andrew Poklepovic; Paul Dent
Journal:  Mol Pharmacol       Date:  2013-12-18       Impact factor: 4.436

Review 5.  ABC of Urology. Urological malignancy--II: Urothelial tumours.

Authors:  C Dawson; H Whitfield
Journal:  BMJ       Date:  1996-04-27

6.  Best practice in the treatment of nonmuscle invasive bladder cancer.

Authors:  Anastasios Anastasiadis; Theo M de Reijke
Journal:  Ther Adv Urol       Date:  2012-02

7.  Possible factors affecting response to intravesical bacillus Calmette-Guérin (Tokyo 172 strain) therapy for carcinoma in situ of the bladder: a multivariate analysis.

Authors:  M Takashi; S Katsuno; H Yuba; S Ohshima; K Wakai; Y Ohno
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

Review 8.  Medical management of patients with refractory carcinoma in situ of the bladder.

Authors:  J C Kim; G D Steinberg
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

9.  Usefulness of urine cytology as a routine work-up in the detection of recurrence in patients with prior non-muscle-invasive bladder cancer: practicality and cost-effectiveness.

Authors:  Bong Gi Ok; Yoon Seob Ji; Young Hwii Ko; Phil Hyun Song
Journal:  Korean J Urol       Date:  2014-10-10

10.  Adjuvant intravesical bacillus calmette-guérin therapy and survival among elderly patients with non-muscle-invasive bladder cancer.

Authors:  Benjamin A Spencer; Russell B McBride; Dawn L Hershman; Donna Buono; Harry W Herr; Mitchell C Benson; Supriya Gupta-Mohile; Alfred I Neugut
Journal:  J Oncol Pract       Date:  2012-10-30       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.